共 9 条
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
Review of the Evidence for the Clinical Utility of Lipoprotein-Associated Phospholipase A 2 as a Cardiovascular Risk Marker.[J].Marshall A. Corson;Peter H. Jones;Michael H. Davidson.The American Journal of Cardiology.2008, 12

